Profile data is unavailable for this security.
About the company
Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.
- Revenue in INR (TTM)2.10bn
- Net income in INR203.13m
- Incorporated1978
- Employees1.03k
- LocationJagsonpal Pharmaceuticals LtdT 210J, ShahpurjatNEW DELHI 110049IndiaIND
- Phone+91 1 126494519
- Fax+91 1 126494708
- Websitehttps://www.jagsonpal.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sakar Healthcare Ltd | 1.56bn | 112.43m | 7.07bn | 325.00 | 62.54 | -- | 23.72 | 4.55 | 5.20 | 5.20 | 71.95 | -- | -- | -- | -- | 4,784,942.00 | -- | 5.26 | -- | 6.28 | 45.62 | 43.47 | 7.22 | 10.12 | -- | 3.10 | -- | -- | 14.99 | 17.58 | -8.53 | 11.76 | 19.05 | -- |
IND Swift Laboratories Ltd | 10.04bn | 4.05bn | 8.09bn | 47.00 | 2.00 | -- | 1.82 | 0.8056 | 68.53 | 68.53 | 170.41 | -- | -- | -- | -- | 213,559,000.00 | -- | 5.00 | -- | 6.13 | 47.54 | 41.12 | 40.36 | 8.52 | -- | 4.68 | -- | 0.00 | 6.10 | 11.10 | 784.44 | 70.82 | 23.60 | -- |
Albert David Ltd | 3.60bn | 707.73m | 8.52bn | 1.50k | 12.04 | -- | 10.99 | 2.37 | 124.02 | 124.02 | 630.61 | -- | -- | -- | -- | 2,403,949.00 | -- | 10.00 | -- | 13.15 | 65.26 | 59.85 | 19.67 | 11.87 | -- | 83.07 | -- | 12.89 | 6.12 | 2.72 | 108.49 | 33.59 | 40.87 | 13.90 |
Wanbury Ltd | 5.60bn | 523.05m | 9.13bn | 1.49k | 17.95 | -- | 13.95 | 1.63 | 15.54 | 15.54 | 168.35 | -- | -- | -- | -- | 3,759,038.00 | -- | 11.63 | -- | -- | 49.35 | 42.46 | 9.33 | 7.62 | -- | 1.76 | -- | -- | 15.21 | 8.02 | 638.26 | -- | 29.87 | -- |
Nectar Lifesciences Ltd | 16.49bn | 61.44m | 9.48bn | 1.69k | 153.62 | -- | 14.14 | 0.5745 | 0.275 | 0.275 | 73.96 | -- | -- | -- | -- | 9,782,218.00 | -- | -0.2956 | -- | -0.541 | 29.64 | 16.49 | 0.3725 | -0.4053 | -- | 1.06 | -- | -- | 10.53 | -9.56 | 120.66 | -36.29 | -5.06 | -- |
Jagsonpal Pharmaceuticals Ltd | 2.10bn | 203.13m | 10.85bn | 1.03k | 54.21 | -- | 47.90 | 5.17 | 7.57 | 7.57 | 78.03 | -- | -- | -- | -- | 2,048,663.00 | -- | 10.95 | -- | 13.29 | 56.41 | 58.13 | 9.67 | 9.21 | -- | 26.27 | -- | 43.81 | -11.83 | 4.58 | -15.94 | 25.50 | -35.69 | 82.06 |
Bajaj Healthcare Ltd | 4.76bn | -133.27m | 11.95bn | 944.00 | -- | -- | 81.22 | 2.51 | -4.82 | -10.30 | 172.62 | -- | -- | -- | -- | 5,041,608.00 | -- | 7.67 | -- | 14.11 | 48.43 | 33.26 | -2.80 | 7.99 | -- | 1.74 | -- | 4.90 | -26.69 | 5.04 | -122.55 | -- | 15.08 | -- |
Ngl Fine Chem Ltd | 3.58bn | 420.29m | 13.12bn | 390.00 | 31.22 | -- | 34.02 | 3.66 | 68.03 | 68.03 | 580.00 | -- | -- | -- | -- | 9,188,328.00 | -- | 15.06 | -- | 19.58 | 52.02 | 43.53 | 11.73 | 13.15 | -- | 26.59 | -- | 3.06 | 21.79 | 17.20 | 101.58 | 15.47 | 14.49 | 0.00 |
Bliss GVS Pharma Ltd | 7.94bn | 814.66m | 13.64bn | 831.00 | 17.02 | -- | 11.73 | 1.72 | 7.63 | 7.63 | 74.93 | -- | -- | -- | -- | 9,559,162.00 | -- | 6.46 | -- | 8.22 | 51.81 | 43.91 | 11.24 | 9.92 | -- | -- | -- | 7.92 | 2.48 | -3.03 | 6.49 | -9.42 | -8.33 | -12.94 |
Lincoln Pharmaceuticals Ltd | 5.92bn | 979.63m | 14.60bn | 1.70k | 14.90 | -- | 13.36 | 2.47 | 48.91 | 48.91 | 295.69 | -- | -- | -- | -- | 3,483,600.00 | -- | 13.95 | -- | 16.54 | 51.92 | 50.65 | 16.54 | 14.71 | -- | 60.93 | -- | 3.44 | 13.76 | 9.66 | 27.99 | 13.88 | 21.54 | 3.71 |
Remus Pharmaceuticals Ltd | 450.27m | 85.03m | 14.67bn | 38.00 | 155.81 | 56.47 | 163.36 | 32.58 | 15.98 | 15.98 | 90.25 | 44.09 | -- | -- | -- | 11,849,290.00 | -- | -- | -- | -- | 52.39 | -- | 18.88 | -- | 1.35 | -- | 0.2933 | -- | 82.17 | -- | 151.14 | -- | -- | -- |
Data as of Sep 23 2024. Currency figures normalised to Jagsonpal Pharmaceuticals Ltd's reporting currency: Indian Rupee INR
Holder | Shares | % Held |
---|---|---|
WhiteOak Capital Asset Management Ltd.as of 31 Aug 2024 | 29.63k | 0.11% |
Motilal Oswal Asset Management Co. Ltd.as of 31 Aug 2024 | 110.00 | 0.00% |
Data from 31 Aug 2024 - 31 Aug 2024Source: FactSet Research Systems Inc.